These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33012200)

  • 1. Postnatal Enalapril to Improve Cardiovascular Function Following Preterm Preeclampsia (PICk-UP):: A Randomized Double-Blind Placebo-Controlled Feasibility Trial.
    Ormesher L; Higson S; Luckie M; Roberts SA; Glossop H; Trafford A; Cottrell E; Johnstone ED; Myers JE
    Hypertension; 2020 Dec; 76(6):1828-1837. PubMed ID: 33012200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure.
    Dyadyk AI; Bagriy AE; Lebed IA; Yarovaya NF; Schukina EV; Taradin GG
    Nephrol Dial Transplant; 1997 May; 12(5):945-51. PubMed ID: 9175047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postnatal cardiovascular morbidity following preterm pre-eclampsia: An observational study.
    Ormesher L; Higson S; Luckie M; Roberts SA; Glossop H; Trafford A; Cottrell E; Johnstone ED; Myers JE
    Pregnancy Hypertens; 2022 Dec; 30():68-81. PubMed ID: 36029727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Associated With Noncompletion During the Run-In Period Before Randomization and Influence on the Estimated Benefit of LCZ696 in the PARADIGM-HF Trial.
    Desai AS; Solomon S; Claggett B; McMurray JJ; Rouleau J; Swedberg K; Zile M; Lefkowitz M; Shi V; Packer M
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (preserve) trial.
    Devereux RB; Palmieri V; Sharpe N; De Quattro V; Bella JN; de Simone G; Walker JF; Hahn RT; Dahlöf B
    Circulation; 2001 Sep; 104(11):1248-54. PubMed ID: 11551875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diastolic function parameters are improved by the addition of simvastatin to enalapril-based treatment in hypertensive individuals.
    Beck AL; Otto ME; D'Avila LB; Netto FM; Armendaris MK; Sposito AC
    Atherosclerosis; 2012 Jun; 222(2):444-8. PubMed ID: 22554359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison study of the echocardiographic changes in hypertensive patients treated with telmisartan vs. enalapril.
    Hadi NR; Abdulzahra MS; Al-Huseini LM; Al-Aubaidy HA
    Int J Cardiol; 2017 Mar; 230():269-274. PubMed ID: 28041700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Remodeling After Hypertensive Pregnancy Following Physician-Optimized Blood Pressure Self-Management: The POP-HT Randomized Clinical Trial Imaging Substudy.
    Kitt J; Krasner S; Barr L; Frost A; Tucker K; Bateman PA; Suriano K; Kenworthy Y; Lapidaire W; Lacharie M; Mills R; Roman C; Mackillop L; Cairns A; Aye C; Ferreira V; Piechnik S; Lukaschuk E; Thilaganathan B; Chappell LC; Lewandowski AJ; McManus RJ; Leeson P
    Circulation; 2024 Feb; 149(7):529-541. PubMed ID: 37950907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect and safety of treatment with ACE-inhibitor Enalapril and β-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - a randomized, double-blind, placebo-controlled trial.
    Dittrich S; Graf E; Trollmann R; Neudorf U; Schara U; Heilmann A; von der Hagen M; Stiller B; Kirschner J; Pozza RD; Müller-Felber W; Weiss K; von Au K; Khalil M; Motz R; Korenke C; Lange M; Wilichowski E; Pattathu J; Ebinger F; Wiechmann N; Schröder R;
    Orphanet J Rare Dis; 2019 May; 14(1):105. PubMed ID: 31077250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of a single oral dose of enalapril among children with asymptomatic chronic mitral regurgitation.
    Calabrò R; Pisacane C; Pacileo G; Russo MG
    Am Heart J; 1999 Nov; 138(5 Pt 1):955-61. PubMed ID: 10539829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Converting enzyme inhibition and left ventricular hypertrophy.
    Fagard R
    Eur Heart J; 1995 Dec; 16(12):1748-9. PubMed ID: 8681996
    [No Abstract]   [Full Text] [Related]  

  • 13. Left ventricular systolic function after marked reduction of ventricular hypertrophy induced by 5 years' enalapril treatment.
    González-Juanatey JR; Pose Reino A; García Acuña JM; Castelo Fuentes V; Amaro Gendón A; Calvo Gómez C; Gil de la Peña M
    Eur Heart J; 1995 Dec; 16(12):1981-7. PubMed ID: 8682036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Enalapril on Preventing Anthracycline-Induced Cardiomyopathy.
    Janbabai G; Nabati M; Faghihinia M; Azizi S; Borhani S; Yazdani J
    Cardiovasc Toxicol; 2017 Apr; 17(2):130-139. PubMed ID: 27003392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind comparison of eprosartan and enalapril on cough and blood pressure in unselected hypertensive patients. Eprosartan Study Group.
    Elliott WJ
    J Hum Hypertens; 1999 Jun; 13(6):413-7. PubMed ID: 10408592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of enalapril initiated early after acute myocardial infarction on heart failure parameters, with reference to clinical class and echocardiographic determinants. CONSENSUS II Multi-Echo Study Group.
    Edner M; Bonarjee VV; Nilsen DW; Berning J; Carstensen S; Caidahl K
    Clin Cardiol; 1996 Jul; 19(7):543-8. PubMed ID: 8818434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.
    Konstam MA; Kronenberg MW; Rousseau MF; Udelson JE; Melin J; Stewart D; Dolan N; Edens TR; Ahn S; Kinan D
    Circulation; 1993 Nov; 88(5 Pt 1):2277-83. PubMed ID: 8222122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
    Coca A; Calvo C; García-Puig J; Gil-Extremera B; Aguilera MT; de la Sierra A; Martín-Hidalgo A; Marín R;
    Clin Ther; 2002 Jan; 24(1):126-38. PubMed ID: 11833827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empagliflozin does not change cardiac index nor systemic vascular resistance but rapidly improves left ventricular filling pressure in patients with type 2 diabetes: a randomized controlled study.
    Rau M; Thiele K; Hartmann NK; Schuh A; Altiok E; Möllmann J; Keszei AP; Böhm M; Marx N; Lehrke M
    Cardiovasc Diabetol; 2021 Jan; 20(1):6. PubMed ID: 33413355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.